Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry.

Canepa M, Fonseca C, Chioncel O, Laroche C, Crespo-Leiro MG, Coats AJS, Mebazaa A, Piepoli MF, Tavazzi L, Maggioni AP; ESC HF Long Term Registry Investigators.

JACC Heart Fail. 2018 Jun;6(6):452-462. doi: 10.1016/j.jchf.2018.02.001.

PMID:
29852929
2.

Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Summary of Recommendations.

Barberà JA, Román A, Gómez-Sánchez MÁ, Blanco I, Otero R, López-Reyes R, Otero I, Pérez-Peñate G, Sala E, Escribano P.

Arch Bronconeumol. 2018 Apr;54(4):205-215. doi: 10.1016/j.arbres.2017.11.014. Epub 2018 Feb 19. English, Spanish.

3.

Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study.

McLaughlin VV, Jansa P, Nielsen-Kudsk JE, Halank M, Simonneau G, Grünig E, Ulrich S, Rosenkranz S, Gómez Sánchez MA, Pulido T, Pepke-Zaba J, Barberá JA, Hoeper MM, Vachiéry JL, Lang I, Carvalho F, Meier C, Mueller K, Nikkho S, D'Armini AM.

BMC Pulm Med. 2017 Dec 28;17(1):216. doi: 10.1186/s12890-017-0563-7.

4.

REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survival.

Benza RL, Farber HW, Frost A, Ghofrani HA, Gómez-Sánchez MA, Langleben D, Rosenkranz S, Busse D, Meier C, Nikkho S, Hoeper MM.

J Heart Lung Transplant. 2018 Apr;37(4):513-519. doi: 10.1016/j.healun.2017.11.006. Epub 2017 Nov 11.

5.

Macitentan in daily clinical practice: A single centre, 1-year experience.

Cadenas-Menéndez S, Álvarez-Vega P, Martín-Moreiras J, Barreiro-Pérez M, Gómez-Sánchez MÁ, Sánchez-Fernández PL.

Pulmonology. 2017 Nov 22. pii: S2173-5115(17)30149-5. doi: 10.1016/j.rppnen.2017.10.001. [Epub ahead of print]

6.

Trends in Pulmonary Hypertension Over a Period of 30 Years: Experience From a Single Referral Centre.

Quezada Loaiza CA, Velázquez Martín MT, Jiménez López-Guarch C, Ruiz Cano MJ, Navas Tejedor P, Carreira PE, Flox Camacho Á, de Pablo Gafas A, Delgado Jiménez JF, Gómez Sánchez MÁ, Escribano Subías P.

Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):915-923. doi: 10.1016/j.rec.2016.12.044. Epub 2017 Apr 26. English, Spanish.

PMID:
28454887
7.

Selection of the Best of 2016 in the Treatment of Pulmonary Hypertension.

Gómez Sánchez MÁ, Barrios Garrido-Lestache E.

Rev Esp Cardiol (Engl Ed). 2017 Apr;70(4):305-306. doi: 10.1016/j.rec.2017.01.010. English, Spanish. No abstract available.

PMID:
28347412
8.

Heart Failure: A New Epidemic of Cardiovascular Disease.

Silva D, Gomez-Sanchez MA.

Acta Med Port. 2016 Jan;29(1):10-1. doi: 10.20344/amp.5909. Epub 2016 Jan 29. No abstract available.

9.

2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):177. doi: 10.1016/j.rec.2016.01.002. No abstract available.

PMID:
26837729
10.

Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry.

Delcroix M, Lang I, Pepke-Zaba J, Jansa P, D'Armini AM, Snijder R, Bresser P, Torbicki A, Mellemkjaer S, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Jaïs X, Ambroz D, Treacy C, Morsolini M, Jenkins D, Lindner J, Dartevelle P, Mayer E, Simonneau G.

Circulation. 2016 Mar 1;133(9):859-71. doi: 10.1161/CIRCULATIONAHA.115.016522. Epub 2016 Jan 29.

PMID:
26826181
11.

Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: Prevalence and Predictors.

Pérez-Peñate GM, Rúa-Figueroa I, Juliá-Serdá G, León-Marrero F, García-Quintana A, Ortega-Trujillo JR, Erausquin-Arruabarrena C, Rodríguez-Lozano C, Cabrera-Navarro P, Ojeda-Betancor N, Gómez-Sánchez MÁ.

J Rheumatol. 2016 Feb;43(2):323-9. doi: 10.3899/jrheum.150451. Epub 2015 Dec 15.

PMID:
26669915
12.

Inoperable chronic thromboembolic pulmonary hypertension treated with riociguat: A case study.

Ortiz-Bautista C, Ochoa-Parra N, Navas-Tejedor P, Morán-Fernández L, Gómez-Sánchez MÁ.

Rev Port Cardiol. 2015 Dec;34(12):777.e1-5. doi: 10.1016/j.repc.2015.06.011. Epub 2015 Nov 26.

PMID:
26632111
13.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M; ESC Scientific Document Group .

Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29. No abstract available.

14.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Eur Respir J. 2015 Oct;46(4):903-75. doi: 10.1183/13993003.01032-2015. Epub 2015 Aug 29. Erratum in: Eur Respir J. 2015 Dec;46(6):1855-6.

15.

Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.

Delgado JF, Reyne AG, de Dios S, López-Medrano F, Jurado A, Juan RS, Ruiz-Cano MJ, Dolores Folgueira M, Gómez-Sánchez MÁ, Aguado JM, Lumbreras C.

J Heart Lung Transplant. 2015 Aug;34(8):1112-9. doi: 10.1016/j.healun.2015.03.015. Epub 2015 Mar 26.

PMID:
25940077
16.

[Updated clinical classification of pulmonary hypertension].

Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Kumar RK, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R.

Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 1:45-54. Turkish.

17.

Pulmonary thromboendarterectomy in 106 patients with chronic thromboembolic pulmonary hypertension.

López Gude MJ, Pérez de la Sota E, Forteza Gil A, Centeno Rodríguez J, Eixerés A, Velázquez MT, Sánchez Nistal MA, Pérez Vela JL, Ruiz Cano MJ, Gómez Sanchez MÁ, Escribano Subías P, Cortina Romero JM.

Arch Bronconeumol. 2015 Oct;51(10):502-8. doi: 10.1016/j.arbres.2014.11.012. Epub 2015 Jan 17. English, Spanish.

18.

Heart transplantation using allografts from older donors: Multicenter study results.

Roig E, Almenar L, Crespo-Leiro M, Segovia J, Mirabet S, Delgado J, Pérez-Villa F, Luís Lambert J, Teresa Blasco M, Muñiz J; rest of the participants of the Spanish Heart Transplantation Registry.

J Heart Lung Transplant. 2015 Jun;34(6):790-6. doi: 10.1016/j.healun.2014.10.006. Epub 2014 Nov 4.

PMID:
25499140
19.

What is the clinical significance of isolated subsegmental pulmonary embolism?

Gómez-Sánchez MA.

Rev Port Pneumol. 2014 Jul-Aug;20(4):179-80. doi: 10.1016/j.rppneu.2014.05.001. Epub 2014 Jun 12. No abstract available.

20.

Updated clinical classification of pulmonary hypertension.

Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R.

J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D34-41. doi: 10.1016/j.jacc.2013.10.029. Review. Erratum in: J Am Coll Cardiol. 2014 Feb 25;63(7):746. J Am Coll Cardiol. 2014 Feb 25;63(7):746.

21.

Quality evaluation of sour and duke cherries cultivated in south-west Europe.

Pérez-Sánchez R, Morales-Corts MR, Gómez-Sánchez MÁ.

J Sci Food Agric. 2013 Aug 15;93(10):2523-30. doi: 10.1002/jsfa.6069. Epub 2013 Mar 8.

PMID:
23483578
22.

Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.

Hoeper MM, Barst RJ, Bourge RC, Feldman J, Frost AE, Galié N, Gómez-Sánchez MA, Grimminger F, Grünig E, Hassoun PM, Morrell NW, Peacock AJ, Satoh T, Simonneau G, Tapson VF, Torres F, Lawrence D, Quinn DA, Ghofrani HA.

Circulation. 2013 Mar 12;127(10):1128-38. doi: 10.1161/CIRCULATIONAHA.112.000765. Epub 2013 Feb 12.

PMID:
23403476
23.

Infections by gram-negative bacilli in patients with pulmonary arterial hypertension treated with intravenous prostacyclin.

Gómez Sánchez MA.

Arch Bronconeumol. 2013 Mar;49(3):128-9. doi: 10.1016/j.arbres.2012.09.003. Epub 2012 Nov 3. English, Spanish. No abstract available.

24.

[ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012].

McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik K, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad Falez, Zeiher A; Avrupa Kardiyoloji Derneği (ESC) Akut ve Kronik Kalp Yetersizliği Tani ve Tedavisi 2012 Görev Grubu; ESC Kalp Yetersizliği Birliğinin Işbirliğiyle hazirlanmiştir; Heart Failure Association.

Turk Kardiyol Dern Ars. 2012 Oct;40 Suppl 3:77-137. Turkish. No abstract available.

25.

Bone loss after heart transplant: effect of alendronate, etidronate, calcitonin, and calcium plus vitamin D3.

Gilfraguas L, Guadalix S, Martinez G, Jodar E, Vara J, Gomez-Sanchez MA, Delgado J, De La Cruz J, Lora D, Hawkins F.

Prog Transplant. 2012 Sep;22(3):237-43.

PMID:
22951500
26.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P; ESC Committee for Practice Guidelines.

Eur J Heart Fail. 2012 Aug;14(8):803-69. doi: 10.1093/eurjhf/hfs105. No abstract available. Erratum in: Eur J Heart Fail. 2013 Mar;15(3):361-2.

27.

Composite hemodynamic method of pulsatile and steady right ventricular afterload predicts early outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.

Ruiz-Cano MJ, Grignola JC, Cortina J, Jimenez C, Velazquez MT, Gomez-Sanchez MA, Delgado J, Escribano P.

Int J Cardiol. 2012 Jul 26;158(3):475-6. doi: 10.1016/j.ijcard.2012.05.066. Epub 2012 Jun 8. No abstract available.

PMID:
22682701
28.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; ESC Committee for Practice Guidelines.

Eur Heart J. 2012 Jul;33(14):1787-847. doi: 10.1093/eurheartj/ehs104. Epub 2012 May 19. No abstract available. Erratum in: Eur Heart J. 2013 Jan;34(2):158.

PMID:
22611136
29.

Survival in pulmonary hypertension in Spain: insights from the Spanish registry.

Escribano-Subias P, Blanco I, López-Meseguer M, Lopez-Guarch CJ, Roman A, Morales P, Castillo-Palma MJ, Segovia J, Gómez-Sanchez MA, Barberà JA; REHAP investigators.

Eur Respir J. 2012 Sep;40(3):596-603. Epub 2012 Feb 23.

30.

[ESC guidelines for treatment of cardiovascular disease in pregnancy].

Regitz-Zagrosek V, Lundqvist CB, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Görenek B, Iung B, Kirby M, Maas AH, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L; Avrupa Kardiyoloji Derneği'nin (ESC) Gebelikte Kardiyovasküler Hastaliklarin Tedavisi için Görev Grubu; Avrupa Jinekoloji Derneği (ESG); Avrupa Pediyatrik Kardiyoloji Derneği (AEPC); Alman Cinsiyete Özgü Tip Derneği (DgesGM) tarafindan onaylanmiştir.

Turk Kardiyol Dern Ars. 2012 Mar;40 Suppl 1:70-120. Turkish. No abstract available.

31.

[Evaluation of perioperative nutritional therapy in patients with gastrointestinal tract neoplasms].

Gómez Sánchez MB, García Talavera Espín NV, Monedero Saiz T, Sánchez Álvarez C, Zomeño Ros AI, Nicolás Hernández M, Gómez Ramos MJ, Parra Baños P, González Valverde FM.

Nutr Hosp. 2011 Sep-Oct;26(5):1073-80. doi: 10.1590/S0212-16112011000500023. Spanish.

32.

Production of a plasmid-encoded OXA-72 β-lactamase associated with resistance to carbapenems in a clinical isolate Acinetobacter junii.

Fernández-Cuenca F, Rodríguez-Martínez JM, Gómez-Sánchez MA, de Alba PD, Infante-Martínez V, Pascual A.

Int J Antimicrob Agents. 2012 Jan;39(1):93-4. doi: 10.1016/j.ijantimicag.2011.07.017. Epub 2011 Oct 7. No abstract available.

PMID:
21982835
33.

Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry.

Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, Treacy C, D'Armini AM, Morsolini M, Snijder R, Bresser P, Torbicki A, Kristensen B, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Hamid AM, Jaïs X, Simonneau G.

Circulation. 2011 Nov 1;124(18):1973-81. doi: 10.1161/CIRCULATIONAHA.110.015008. Epub 2011 Oct 3.

34.

Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like.

Fernández-Cuenca F, Smani Y, Gómez-Sánchez MC, Docobo-Pérez F, Caballero-Moyano FJ, Domínguez-Herrera J, Pascual A, Pachón J.

Int J Antimicrob Agents. 2011 Dec;38(6):548-9. doi: 10.1016/j.ijantimicag.2011.08.002. Epub 2011 Sep 21. No abstract available.

PMID:
21940150
35.

[Perioperative nutritional support in patients with colorectal neoplasms].

Gómez Sánchez MB, García-Talavera Espín NV, Sánchez Álvarez C, Zomeño Ros AI, Hernández MN, Gómez Ramos MJ, Parra Baños P, González Valverde FM.

Nutr Hosp. 2010 Sep-Oct;25(5):797-805. Spanish.

36.

Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension.

Barst RJ, Oudiz RJ, Beardsworth A, Brundage BH, Simonneau G, Ghofrani HA, Sundin DP, Galiè N; Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group.

J Heart Lung Transplant. 2011 Jun;30(6):632-43. doi: 10.1016/j.healun.2010.11.009. Epub 2011 Jan 21.

PMID:
21256048
37.

Induction treatment with monoclonal antibodies for heart transplantation.

Delgado JF, Vaqueriza D, Sánchez V, Escribano P, Ruiz-Cano MJ, Renes E, Gómez-Sánchez MA, Cortina JM, de la Calzada CS.

Transplant Rev (Orlando). 2011 Jan;25(1):21-6. doi: 10.1016/j.trre.2010.10.002. Review.

PMID:
21126660
38.

Risk factors associated with moderate-to-severe renal dysfunction among heart transplant patients: results from the CAPRI study.

Delgado JF, Crespo-Leiro MG, Gómez-Sánchez MA, Paniagua MJ, González-Vílchez F, Vázquez de Prada JA, Fernández-Yáñez J, Pascual D, Almenar L, Martínez-Dolz L, Díaz B, Roig E, Segovia J, Arizón JM, Garrido I, Blasco T, López J, Brossa V, Manito N, Muñiz J.

Clin Transplant. 2010 Sep-Oct;24(5):E194-200. doi: 10.1111/j.1399-0012.2010.01249.x.

PMID:
20597926
39.

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.

Konstam MA, Neaton JD, Dickstein K, Drexler H, Komajda M, Martinez FA, Riegger GA, Malbecq W, Smith RD, Guptha S, Poole-Wilson PA; HEAAL Investigators.

Lancet. 2009 Nov 28;374(9704):1840-8. doi: 10.1016/S0140-6736(09)61913-9. Epub 2009 Nov 16. Erratum in: Lancet. 2009 Dec 5;374(9705):1888.

PMID:
19922995
40.

Guidelines for the diagnosis and treatment of pulmonary hypertension.

Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT), Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G.

Eur Respir J. 2009 Dec;34(6):1219-63. doi: 10.1183/09031936.00139009. Epub 2009 Sep 12. No abstract available.

41.

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G; ESC Committee for Practice Guidelines (CPG).

Eur Heart J. 2009 Oct;30(20):2493-537. doi: 10.1093/eurheartj/ehp297. Epub 2009 Aug 27. No abstract available. Erratum in: Eur Heart J. 2011 Apr;32(8):926.

PMID:
19713419
42.

Tadalafil therapy for pulmonary arterial hypertension.

Galiè N, Brundage BH, Ghofrani HA, Oudiz RJ, Simonneau G, Safdar Z, Shapiro S, White RJ, Chan M, Beardsworth A, Frumkin L, Barst RJ; Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group.

Circulation. 2009 Jun 9;119(22):2894-903. doi: 10.1161/CIRCULATIONAHA.108.839274. Epub 2009 May 26. Erratum in: Circulation. 2011 Sep 6;124(10):e279. Dosage error in article text.

PMID:
19470885
43.

End-stage heart disease in the elderly.

Martínez-Sellés M, Vidán MT, López-Palop R, Rexach L, Sánchez E, Datino T, Cornide M, Carrillo P, Ribera JM, Díaz-Castro O, Bañuelos C; Spanish Society of Cardiology Section on Geriatric Cardiology "Endstage heart disease in the elderly" working group.

Rev Esp Cardiol. 2009 Apr;62(4):409-21. Review. English, Spanish.

44.

Long-term inhaled nitric oxide plus phosphodiesterase 5 inhibitors for severe pulmonary hypertension.

Pérez-Peñate GM, Juliá-Serdà G, Ojeda-Betancort N, García-Quintana A, Pulido-Duque J, Rodríguez-Pérez A, Cabrera-Navarro P, Gómez-Sánchez MA.

J Heart Lung Transplant. 2008 Dec;27(12):1326-32. doi: 10.1016/j.healun.2008.08.007. Epub 2008 Oct 26.

PMID:
19059113
45.

[Update on geriatric cardiology].

Martínez-Sellés M, Datino T, Gómez Sánchez MA, Bañuelos C.

Rev Esp Cardiol. 2008 Feb;61 Suppl 1:4-14. Review. Spanish.

PMID:
18341931
46.

[Transition from prostacyclin to bosentan in five patients with severe pulmonary hypertension: the switch is possible].

Flox Camacho A, Escribano Subías P, Tello de Meneses R, Delgado Jiménez J, Gómez Sánchez MA, Sáenz de la Calzada C.

Rev Esp Cardiol. 2006 Jul;59(7):737-9. Spanish.

47.

A randomized multicenter comparison of basiliximab and muromonab (OKT3) in heart transplantation: SIMCOR study.

Segovia J, Rodríguez-Lambert JL, Crespo-Leiro MG, Almenar L, Roig E, Gómez-Sánchez MA, Lage E, Manito N, Alonso-Pulpón L.

Transplantation. 2006 Jun 15;81(11):1542-8.

PMID:
16770243
48.

[Advances in geriatric cardiology].

Gómez Sánchez MA, Bañuelos de Lucas C, Ribera Casado JM, Pérez Casar F.

Rev Esp Cardiol. 2006;59 Suppl 1:105-9. Review. Spanish.

49.

BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension.

Aldred MA, Vijayakrishnan J, James V, Soubrier F, Gomez-Sanchez MA, Martensson G, Galie N, Manes A, Corris P, Simonneau G, Humbert M, Morrell NW, Trembath RC.

Hum Mutat. 2006 Feb;27(2):212-3.

PMID:
16429403
50.

An unusual indication for cardiac transplantation: isolated myocardial tuberculosis.

López Gude MJ, Pérez de la Sota E, Cortina Romero JM, Delgado JF, Gómez Sánchez MA, Aguado JM, Rufilanchas Sánchez JJ.

J Heart Lung Transplant. 2006 Jan;25(1):128-30. Epub 2005 Nov 17.

PMID:
16399542

Supplemental Content

Loading ...
Support Center